Morgan Stanley upgraded Manhattan Associates (MANH) to Equal Weight from Underweight with a price target of $200, up from $195. The shares are down post the Q3 report on slower remaining performance obligation bookings and an expectations miss on the fiscal 2026 outlook, the analyst tells investors in a research note. The firm now sees no near-term more negative catalysts and believes its Underweight thesis has played out.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MANH:
- Manhattan Associates: Upgraded to Hold Amid Improved Risk/Reward Profile Despite RPO Concerns
- Manhattan Associates Reports Strong Q3 2025 Results
- Manhattan Associates Reports Strong Q3 2025 Financial Results
- Manhattan Associates board replenished share repurchase authority to $100M
- Manhattan Associates announces appointment of Betz as Chief Operating Officer